NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a company “Advancing Drugs Through Glycoscience®", today announced that the U.S. Securities and Exchange Commission (SEC) has declared its shelf registration statement relating to the offer and sale of up to $10 million of securities is effective.
